Skip to main content

Enhabit, Inc.

corporate_fare Company Profile

Enhabit, Inc.

EHAB·NYSE·Healthcare·CIK 0001803737

Enhabit is a leading provider of home health and hospice services in the United States. The company delivers clinical care to patients in their homes and has been operating for over 25 years. As of December 31, 2025, Enhabit operated 249 home health and 117 hospice locations across 34 states. The business operates in two segments: Home Health and Hospice. Both segments offer a comprehensive range of high-quality, Medicare-certified services. The Home Health segment provides skilled home health services, including nursing care, physical, occupational, and speech therapy, medical social work, and home health aide services. For the year ended December 31, 2025, the Home Health segment had an average daily census of 41,786 and generated $813.8 million in Net service revenue, representing 76.8% of Enhabit's total Net service revenue. The Hospice segment provides skilled hospice services, including nursing care, pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and family member bereavement support to terminally ill patients and their families. For the year ended December 31, 2025, the Hospice segment had an average daily census of 3,985 patients and generated $246.2 million in Net service revenue, representing 23.2% of Enhabit's total Net service revenue. Enhabit is a Delaware corporation, founded in 1998 and headquartered in Dallas, Texas. It became an independent public company on July 1, 2022, after operating as a reporting segment of Encompass Health Corporation from December 2014.

Enhabit, Inc. (NYSE:EHAB) is a publicly traded company in the Healthcare sector. Wiseek has independently scored 16 items for EHAB at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-05-15, rated 10/10. Across its 16 most recent items scored 7 or higher, the top rating is 10/10, with 14 rated 8 or above. Recent SEC coverage for EHAB spans 8-K, 10-Q, DEFM14A, PREM14A.

Recent high-impact activity:

  • Enhabit Completes Acquisition by Kinderhook, Delists from NYSE
  • Shareholders Approve $1.1B Acquisition by Kinderhook; Merger Expected May 15
  • Enhabit Reports Strong Q1 Operating Income Driven by Legal Settlement, Refinances Debt Amidst Pending Acquisition
  • Enhabit Faces Shareholder Lawsuits Challenging Kinderhook Merger, Updates Proxy with New Financial Projections
  • Enhabit Receives Early HSR Termination, Advancing $1.1B Merger with Kinderhook

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.06B
Net Income
-$4.6M
Diluted EPS
-$0.09
Op. Cash Flow
$70.7M
Free Cash Flow
$65.8M
Operating Income
$16.1M
Cash & Equivalents
$43.6M
Debt / Equity
0.00×
Net Margin
-0.4%
Shares Outstanding
50.72M sh
Source: 10-K · filed 2026-04-30 · accession 0001803737-26-000020
Browse all tickers starting with E →

No longer listed

EHAB (Enhabit, Inc.) is no longer listed on a major US exchange, so Wiseek no longer shows market data for this symbol. It last appeared on NYSE. Enhabit, Inc was acquired by Kinderhook. The filings and coverage below remain available as an archive.

feed EHAB - Latest Insights

EHAB
May 15, 2026, 9:06 AM EDT
Filing Type: 8-K
Importance Score:
10
EHAB
May 12, 2026, 1:33 PM EDT
Filing Type: 8-K
Importance Score:
9
EHAB
May 07, 2026, 4:26 PM EDT
Filing Type: 10-Q
Importance Score:
7
EHAB
May 05, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
8
EHAB
Apr 16, 2026, 4:28 PM EDT
Filing Type: 8-K
Importance Score:
8
EHAB
Apr 16, 2026, 4:17 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
EHAB
Apr 14, 2026, 4:06 PM EDT
Filing Type: DEFM14A
Importance Score:
9
EHAB
Mar 30, 2026, 9:02 AM EDT
Filing Type: PREM14A
Importance Score:
9
EHAB
Mar 25, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
7
EHAB
Mar 04, 2026, 7:31 PM EST
Filing Type: 10-K
Importance Score:
8
EHAB
Mar 04, 2026, 7:01 PM EST
Filing Type: DEFA14A
Importance Score:
8
EHAB
Mar 04, 2026, 7:00 PM EST
Filing Type: 8-K
Importance Score:
8
EHAB
Feb 23, 2026, 4:59 PM EST
Filing Type: DEFA14A
Importance Score:
9
EHAB
Feb 23, 2026, 4:57 PM EST
Filing Type: DEFA14A
Importance Score:
10
EHAB
Feb 23, 2026, 4:51 PM EST
Filing Type: 8-K
Importance Score:
9
EHAB
Feb 12, 2026, 8:51 AM EST
Filing Type: 8-K
Importance Score:
8
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets